Message Font: Serif | Sans-Serif
No. of Recommendations: 1
Hey Rob,

I'm curious what you think of the ISRG move. I know that they're always fending off studies and commentary, but this seems a little larger than normal. Multiple credible sources are questioning the economics and the FDA incident review is piling on at the same time.

The thing I like the least is last evening's reversal on the increase in incident frequency. When the FDA initiated the review, ISRG's initial comment was a denial that there was an increase in reportable incidents. Then they come out yesterday ans say there was an increase, but it was due to how they've reclassified certain incidents.

Intuitive Surgical Inc. (ISRG) said changes in how it reports adverse events resulted in an increased number of reports sent to U.S. regulators, as well as more incidents being classified as resulting in serious injury. The company, maker of the da Vinci robotic surgery machines, said the rise in adverse event reporting "does not reflect a change in product performance."

-Dow JOnes Newswire

It's don't care for that news. The price action has also swung radically. I decided to protect my gains and closed the position at a nice gain. Not as nice as it could have been, and I still like the company a lot. I just don't like the idea of fighting the tape in a market that feels a little top heavy. Thoughts?


(Sorry for the OT guys...)
Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.